Millennium Management LLC Reduces Stake in Zentalis Pharmaceuticals

Millennium Management LLC has filed an amendment to its Schedule 13G, disclosing a significant reduction in its stake in Zentalis Pharmaceuticals, Inc. As of September 30, 2025, Millennium Management LLC owns 902,521 shares, representing a 1.3% ownership in the company. This marks a decrease of 2,574,287 shares (74.04%) from its previous holdings. The filing also includes Millennium Group Management LLC and Israel A. Englander as joint filers. The amendment was signed by Gil Raviv, Global General Counsel, and Israel A. Englander on October 13, 2025. The filing indicates that the shares are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers controlled by Millennium Group Management LLC and Mr. Englander.